Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
BOM:543520'
s FCF Yield % Range Over the Past 10 Years
Min: -106.8 Med: 10.09 Max: 117.35
Current: -32.94
During the past 8 years, the highest FCF Yield % of Global Longlife Hospital & Research was 117.35%. The lowest was -106.80%. And the median was 10.09%.
BOM:543520's FCF Yield % is ranked worse than 91.64% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 1.825
vs BOM:543520: -32.94
Global Longlife Hospital & Research FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Global Longlife Hospital & Research FCF Yield % Related Terms
Global Longlife Hospital & Research FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Longlife Hospital & Research FCF Yield % Chart
BOM:543520 vs HCA, THC, DVA: FCF Yield % Comparison
For the Medical Care Facilities subindustry, Global Longlife Hospital & Research's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Longlife Hospital & Research FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Longlife Hospital & Research's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Global Longlife Hospital & Research's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Longlife Hospital & Research (BOM:543520) has a FCF Yield % of -32.94 as of Aug. 09, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Global Longlife Hospital & Research and its competitors. According to the industry distribution chart, Global Longlife Hospital & Research ranks #625 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 91.6%.
Is Global Longlife Hospital & Research's FCF Yield % too high?
Global Longlife Hospital & Research's current FCF Yield % is -32.94. Based on the distribution chart, Global Longlife Hospital & Research ranks #625 out of 682 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Global Longlife Hospital & Research has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Global Longlife Hospital & Research's FCF Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Longlife Hospital & Research ranks #625 out of 682 companies for FCF Yield %. This places Global Longlife Hospital & Research in the lower half of its industry. The industry median FCF Yield % is 1.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.83, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Global Longlife Hospital & Research and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Longlife Hospital & Research's current FCF Yield % is -32.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Longlife Hospital & Research stock overvalued right now?
Based on GuruFocus' analysis, Global Longlife Hospital & Research (BOM:543520) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1.37, compared to a current price of ₹13.04 — trading 851.8% above its estimated fair value. The current FCF Yield % is -32.94. Global Longlife Hospital & Research's overall GF Score™ is 36/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Global Longlife Hospital & Research (BOM:543520), the current FCF Yield % is -32.94 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Global Longlife Hospital & Research (BOM:543520) Overvalued in 2026?
Based on GuruFocus' analysis, Global Longlife Hospital & Research stock appears to be overvalued.
The current stock price of ₹13.04 is trading 851.8% above its estimated GF Value™ of ₹1.37.
GuruFocus considers Global Longlife Hospital & Research to be Significantly Overvalued.
Key valuation signals for BOM:543520:
FCF Yield %: -32.94
GF Value™: ₹1.37 vs. price of ₹13.04 (851.8% above fair value)
No single metric tells the full story. See the BOM:543520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Global Longlife Hospital & Research Ltd is Multispecialty Hospital providing Medical & Allied Services. The company operates in the single segment i.e. Health Care and Hospital. Its services are Medical, Surgical, Radiology, Pathology, and Other Services.
36GF Score
Get the complete analysis for BOM:543520
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543520 has been successfully added to your 
